{"data":[{"accessionNo":"0001140361-26-021322","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001374690","issuerName":"Larimar Therapeutics, Inc.","ticker":"LRMR","cusip":"517125100","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-03-31","reportingPerson":"Blue Owl Capital Holdings LP","reportingCik":null,"personType":"PN","sharesOwned":10739492,"percentOfClass":9.99,"filedAt":"2026-05-14","canonicalUrl":"https://xoomar.com/markets/stocks/lrmr"},{"accessionNo":"0001104659-26-053218","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001374690","issuerName":"Larimar Therapeutics, Inc.","ticker":"LRMR","cusip":"517125100","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-03-31","reportingPerson":"Israel A. Englander","reportingCik":null,"personType":"IN","sharesOwned":3625278,"percentOfClass":3.5,"filedAt":"2026-04-30","canonicalUrl":"https://xoomar.com/markets/stocks/lrmr"},{"accessionNo":"0001104659-26-053218","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001374690","issuerName":"Larimar Therapeutics, Inc.","ticker":"LRMR","cusip":"517125100","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-03-31","reportingPerson":"Millennium Group Management LLC","reportingCik":null,"personType":"OO","sharesOwned":3625278,"percentOfClass":3.5,"filedAt":"2026-04-30","canonicalUrl":"https://xoomar.com/markets/stocks/lrmr"},{"accessionNo":"0001104659-26-053218","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001374690","issuerName":"Larimar Therapeutics, Inc.","ticker":"LRMR","cusip":"517125100","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-03-31","reportingPerson":"Millennium Management LLC","reportingCik":null,"personType":"OO","sharesOwned":3625278,"percentOfClass":3.5,"filedAt":"2026-04-30","canonicalUrl":"https://xoomar.com/markets/stocks/lrmr"},{"accessionNo":"0001193805-26-000206","formType":"SCHEDULE 13D/A","amendmentNo":11,"issuerCik":"0001374690","issuerName":"Larimar Therapeutics, Inc.","ticker":"LRMR","cusip":null,"securityClass":"Common Stock, par value $0.01 per share","eventDate":"2026-02-27","reportingPerson":"Deerfield Management Company, L.P.","reportingCik":"0001009258","personType":"PN","sharesOwned":35667474,"percentOfClass":34.41,"filedAt":"2026-03-02","canonicalUrl":"https://xoomar.com/markets/stocks/lrmr"},{"accessionNo":"0001193805-26-000206","formType":"SCHEDULE 13D/A","amendmentNo":11,"issuerCik":"0001374690","issuerName":"Larimar Therapeutics, Inc.","ticker":"LRMR","cusip":null,"securityClass":"Common Stock, par value $0.01 per share","eventDate":"2026-02-27","reportingPerson":"James E. Flynn","reportingCik":"0001352546","personType":"IN","sharesOwned":35667474,"percentOfClass":34.41,"filedAt":"2026-03-02","canonicalUrl":"https://xoomar.com/markets/stocks/lrmr"},{"accessionNo":"0001193805-26-000206","formType":"SCHEDULE 13D/A","amendmentNo":11,"issuerCik":"0001374690","issuerName":"Larimar Therapeutics, Inc.","ticker":"LRMR","cusip":null,"securityClass":"Common Stock, par value $0.01 per share","eventDate":"2026-02-27","reportingPerson":"Deerfield Private Design Fund IV, L.P.","reportingCik":"0001680307","personType":"PN","sharesOwned":10622957,"percentOfClass":10.25,"filedAt":"2026-03-02","canonicalUrl":"https://xoomar.com/markets/stocks/lrmr"},{"accessionNo":"0001193805-26-000206","formType":"SCHEDULE 13D/A","amendmentNo":11,"issuerCik":"0001374690","issuerName":"Larimar Therapeutics, Inc.","ticker":"LRMR","cusip":null,"securityClass":"Common Stock, par value $0.01 per share","eventDate":"2026-02-27","reportingPerson":"Deerfield Mgmt III, L.P.","reportingCik":"0001610540","personType":"PN","sharesOwned":10622928,"percentOfClass":10.25,"filedAt":"2026-03-02","canonicalUrl":"https://xoomar.com/markets/stocks/lrmr"},{"accessionNo":"0001193805-26-000206","formType":"SCHEDULE 13D/A","amendmentNo":11,"issuerCik":"0001374690","issuerName":"Larimar Therapeutics, Inc.","ticker":"LRMR","cusip":null,"securityClass":"Common Stock, par value $0.01 per share","eventDate":"2026-02-27","reportingPerson":"Deerfield Mgmt IV, L.P.","reportingCik":"0001713467","personType":"PN","sharesOwned":10622957,"percentOfClass":10.25,"filedAt":"2026-03-02","canonicalUrl":"https://xoomar.com/markets/stocks/lrmr"},{"accessionNo":"0001193805-26-000206","formType":"SCHEDULE 13D/A","amendmentNo":11,"issuerCik":"0001374690","issuerName":"Larimar Therapeutics, Inc.","ticker":"LRMR","cusip":null,"securityClass":"Common Stock, par value $0.01 per share","eventDate":"2026-02-27","reportingPerson":"Deerfield Private Design Fund III, L.P.","reportingCik":"0001603333","personType":"PN","sharesOwned":10622928,"percentOfClass":10.25,"filedAt":"2026-03-02","canonicalUrl":"https://xoomar.com/markets/stocks/lrmr"},{"accessionNo":"0001193805-26-000206","formType":"SCHEDULE 13D/A","amendmentNo":11,"issuerCik":"0001374690","issuerName":"Larimar Therapeutics, Inc.","ticker":"LRMR","cusip":null,"securityClass":"Common Stock, par value $0.01 per share","eventDate":"2026-02-27","reportingPerson":"Deerfield Healthcare Innovations Fund, L.P.","reportingCik":"0001646981","personType":"PN","sharesOwned":8153107,"percentOfClass":7.87,"filedAt":"2026-03-02","canonicalUrl":"https://xoomar.com/markets/stocks/lrmr"},{"accessionNo":"0001193805-26-000206","formType":"SCHEDULE 13D/A","amendmentNo":11,"issuerCik":"0001374690","issuerName":"Larimar Therapeutics, Inc.","ticker":"LRMR","cusip":null,"securityClass":"Common Stock, par value $0.01 per share","eventDate":"2026-02-27","reportingPerson":"Deerfield Mgmt HIF, L.P.","reportingCik":"0001665736","personType":"PN","sharesOwned":8153107,"percentOfClass":7.87,"filedAt":"2026-03-02","canonicalUrl":"https://xoomar.com/markets/stocks/lrmr"},{"accessionNo":"0001193805-26-000206","formType":"SCHEDULE 13D/A","amendmentNo":11,"issuerCik":"0001374690","issuerName":"Larimar Therapeutics, Inc.","ticker":"LRMR","cusip":null,"securityClass":"Common Stock, par value $0.01 per share","eventDate":"2026-02-27","reportingPerson":"Deerfield Mgmt, L.P.","reportingCik":"0001010823","personType":"PN","sharesOwned":6207982,"percentOfClass":5.99,"filedAt":"2026-03-02","canonicalUrl":"https://xoomar.com/markets/stocks/lrmr"},{"accessionNo":"0001193805-26-000206","formType":"SCHEDULE 13D/A","amendmentNo":11,"issuerCik":"0001374690","issuerName":"Larimar Therapeutics, Inc.","ticker":"LRMR","cusip":null,"securityClass":"Common Stock, par value $0.01 per share","eventDate":"2026-02-27","reportingPerson":"Deerfield Partners, L.P.","reportingCik":"0001301041","personType":"PN","sharesOwned":6207982,"percentOfClass":5.99,"filedAt":"2026-03-02","canonicalUrl":"https://xoomar.com/markets/stocks/lrmr"},{"accessionNo":"0001346824-26-000047","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001374690","issuerName":"Larimar Therapeutics, Inc.","ticker":"LRMR","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-12-31","reportingPerson":"RA Capital Management, L.P.","reportingCik":null,"personType":"IA,PN","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/lrmr"},{"accessionNo":"0001346824-26-000047","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001374690","issuerName":"Larimar Therapeutics, Inc.","ticker":"LRMR","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-12-31","reportingPerson":"Peter Kolchinsky","reportingCik":null,"personType":"HC,IN","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/lrmr"},{"accessionNo":"0001346824-26-000047","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001374690","issuerName":"Larimar Therapeutics, Inc.","ticker":"LRMR","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-12-31","reportingPerson":"Rajeev Shah","reportingCik":null,"personType":"HC,IN","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/lrmr"},{"accessionNo":"0001346824-26-000047","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001374690","issuerName":"Larimar Therapeutics, Inc.","ticker":"LRMR","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-12-31","reportingPerson":"RA Capital Healthcare Fund, L.P.","reportingCik":null,"personType":"PN","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/lrmr"},{"accessionNo":"0001140361-26-005033","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001374690","issuerName":"Larimar Therapeutics, Inc.","ticker":"LRMR","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-12-31","reportingPerson":"Blue Owl Capital Holdings LP","reportingCik":null,"personType":"PN","sharesOwned":8464663,"percentOfClass":9.99,"filedAt":"2026-02-12","canonicalUrl":"https://xoomar.com/markets/stocks/lrmr"},{"accessionNo":"0001104659-25-107757","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001374690","issuerName":"Larimar Therapeutics, Inc.","ticker":"LRMR","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-09-30","reportingPerson":"Millennium Management LLC","reportingCik":null,"personType":"OO","sharesOwned":4966831,"percentOfClass":5.8,"filedAt":"2025-11-06","canonicalUrl":"https://xoomar.com/markets/stocks/lrmr"},{"accessionNo":"0001104659-25-107757","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001374690","issuerName":"Larimar Therapeutics, Inc.","ticker":"LRMR","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-09-30","reportingPerson":"Millennium Group Management LLC","reportingCik":null,"personType":"OO","sharesOwned":4966831,"percentOfClass":5.8,"filedAt":"2025-11-06","canonicalUrl":"https://xoomar.com/markets/stocks/lrmr"},{"accessionNo":"0001104659-25-107757","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001374690","issuerName":"Larimar Therapeutics, Inc.","ticker":"LRMR","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-09-30","reportingPerson":"Israel A. Englander","reportingCik":null,"personType":"IN","sharesOwned":4966831,"percentOfClass":5.8,"filedAt":"2025-11-06","canonicalUrl":"https://xoomar.com/markets/stocks/lrmr"}],"updatedAt":"2026-11-03T21:41:35.845Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","canonicalUrl":"https://xoomar.com/markets/stocks/lrmr","meta":{"source":"SEC","sourceAttribution":"Schedule 13D and 13G data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}